The Clinical and Metabolic Effects of Intragastric Balloon on Morbid Obesity and Its Related Comorbidities

키워드

참고문헌 (72)

1. Kushner RF, "Introduction : the state of obesity in 2017", Med Clin North Am, 102, pp.1~11 (2018)
2. Segula D, "Complications of obesity in adults : a short review of the literature", Malawi Med J, 26, pp.20~24 (2014)
3. Aune D, "BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants", BMJ, 353, pp.i2156~ (2016)
4. Global BMI Mortality Collaboration, "Body-mass index and all-cause mortality : individual-participant-data meta-analysis of 239 prospective studies in four continents", Lancet, 388, pp.776~786 (2016)
5. Buchwald H, "Weight and type 2 diabetes after bariatric surgery : systematic review and meta-analysis", Am J Med, 122, pp.248~256 (2009)
6. Schauer PR, "Bariatric surgery versus intensive medical therapy in obese patients with diabetes", N Engl J Med, 366, pp.1567~1576 (2012)
7. Morino M, "Mortality after bariatric surgery : analysis of 13, 871 morbidly obese patients from a national registry", Ann Surg, 246, pp.1002~1007 (2007)
8. Sullivan S, "Endoscopic bariatric and metabolic therapies : new and emerging technologies", Gastroenterology, 152, pp.1791~1801 (2017)
9. Geliebter A, "Gastric distention by balloon and testmeal intake in obese and lean subjects", Am J Clin Nutr, 48, pp.592~594 (1988)
10. Stefater MA, "All bariatric surgeries are not created equal : insights from mechanistic comparisons", Endocr Rev, 33, pp.595~622 (2012)
11. Nieben OG, "Intragastric balloon as an artificial bezoar for treatment of obesity", Lancet, 1, pp.198~199 (1982)
12. Benjamin SB, "Double-blind controlled trial of the Garren-Edwards gastric bubble : an adjunctive treatment for exogenous obesity", Gastroenterology, 95, pp.581~588 (1988)
13. "Summary of safety and effectiveness data (SSED): ORBERATM Intragastric Balloon System" (2015)[URL]
14. "Summary of safety and effectiveness data (SSED): ReShapeTM Integrated Dual Balloon System" (2015)[URL]
15. "Summary of safety and effectiveness data (SSED): Obalon Balloon System" (2016)[URL]
16. "ReShapeTM integrated dual balloon system instructions for use" (2015)[URL]
17. Machytka E, "Adjustable intragastric balloons : a 12-month pilot trial in endoscopic weight loss management", Obes Surg, 21, pp.1499~1507 (2011)
18. Lopasso FP, "A pilot study to evaluate the safety, tolerance, and efficacy of a novel stationary antral balloon(SAB)for obesity", J Clin Gastroenterol, 42, pp.48~53 (2008)
19. Machytka E, "ElipseTM, a procedureless gastric balloon for weight loss : a proof-of-concept pilot study", Obes Surg, 26, pp.512~516 (2016)
20. Trande P, "Efficacy, tolerance and safety of new intragastric air-filled balloon(Heliosphere BAG)for obesity : the experience of 17 cases", Obes Surg, 20, pp.1227~1230 (2010)
21. Bužga M, "Effects of the intragastric balloon MedSil on weight loss, fat tissue, lipid metabolism, and hormones involved in energy balance", Obes Surg, 24, pp.909~915 (2014)
22. Żurawiński W, "Evaluation of the results of treatment of morbid obesity by the endoscopic intragastric balloon implantation method", Wideochir Inne Tech Maloinwazyjne, 12, pp.37~48 (2017)
23. Buzga M, "Short-term outcomes of the new intragastric balloon End-Ball®for treatment of obesity", Wideochir Inne Tech Maloinwazyjne, 11, pp.229~235 (2016)
24. Bazerbachi F, "Fluid-filled versus gas-filled intragastric balloons as obesity interventions : a network meta-analysis of randomized trials", Obes Surg, 28, pp.2617~2625 (2018)
25. Seong Ji Choi, "Various Intragastric Balloons Under Clinical Investigation", Clinical Endoscopy, 51(5), pp.407~415 (2018), 대한소화기내시경학회
26. Trang J, "Incidence of nausea and vomiting after intragastric balloon placement in bariatric patients-a systematic review and meta-analysis", Int J Surg, 57, pp.22~29 (2018)
27. Brill JV, "Reimbursement for endoscopic bariatric therapies", Gastrointest Endosc Clin N Am, 27, pp.343~351 (2017)
28. Doldi SB, "Treatment of morbid obesity with intragastric balloon in association with diet", Obes Surg, 12, pp.583~587 (2002)
29. ASGE Bariatric Endoscopy Task Force and ASGE Technology Committee, "ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies", Gastrointest Endosc, 82, pp.425~438 (2015)
30. Yorke E, "Intragastric balloon for management of severe obesity : a systematic review", Obes Surg, 26, pp.2248~2254 (2016)
31. Choudhary NS, "Intragastric balloon as a novel modality for weight loss in patients with cirrhosis and morbid obesity awaiting liver transplantation", Indian J Gastroenterol, 35, pp.113~116 (2016)
32. Gentileschi P, "Intragastric balloon followed by biliopancreatic diversion in a liver transplant recipient : a case report", Obes Surg, 19, pp.1460~1463 (2009)
33. Al-Sabah S, "Intragastric balloon as a bridge procedure in patients with high body mass index", Surg Obes Relat Dis, 12, pp.1900~1901 (2016)
34. Coffin B, "Impact of intragastric balloon before laparoscopic gastric bypass on patients with super obesity : a randomized multicenter study", Obes Surg, 27, pp.902~909 (2017)
35. Frutos MD, "Intragastric balloon reduces liver volume in super-obese patients, facilitating subsequent laparoscopic gastric bypass", Obes Surg, 17, pp.150~154 (2007)
36. Storm AC, "Intragastric balloon for management of morbid obesity in a candidate for heart transplantation", J Heart Lung Transplant, 36, pp.820~821 (2017)
37. Genco A, "BioEnterics intragastric balloon : the Italian experience with 2, 515 patients", Obes Surg, 15, pp.1161~1164 (2005)
38. Imaz I, "Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis", Obes Surg, 18, pp.841~846 (2008)
39. Genco A, "BioEnterics Intragastric Balloon (BIB): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients", Int J Obes(Lond), 30, pp.129~133 (2006)
40. Konopko-Zubrzycka M, "The effect of intragastric balloon on plasma ghrelin, leptin, and adiponectin levels in patients with morbid obesity", J Clin Endocrinol Metab, 94, pp.1644~1649 (2009)
41. Farina MG, "Intragastric balloon in association with lifestyle and", or pharmacotherapy in the long-term management of obesity, 2012, pp.22, 565~571
42. Lee YM, "Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis : a pilot study", Gastrointest Endosc, 76, pp.756~760 (2012)
43. Fuller NR, "An intragastric balloon in the treatment of obese individuals with metabolic syndrome: a randomized controlled study", Obesity(Silver Spring), 21, pp.1561~1570 (2013)
44. Peker Y, "Comparison of results of laparoscopic gastric banding and consecutive intragastric balloon application at 18 months : a clinical prospective study", J Laparoendosc Adv Surg Tech A, 21, pp.471~475 (2011)
45. Ponce J, "The REDUCE pivotal trial : a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity", Surg Obes Relat Dis, 11, pp.874~881 (2015)
46. Sullivan S, "Randomized sham-controlled trial of the 6-month swallowable gas-filled intragastric balloon system for weight loss", Surg Obes Relat Dis, 14, pp.1876~1889 (2018)
47. Moura D, "Effectiveness of intragastric balloon for obesity : a systematic review and meta-analysis based on randomized control trials", Surg Obes Relat Dis, 12, pp.420~429 (2016)
48. Saber AA, "Efficacy of first-time intragastric balloon in weight loss : a systematic review and meta-analysis of randomized controlled trials", Obes Surg, 27, pp.277~287 (2017)
49. Kotinda A, "Efficacy of intragastric balloons for weight loss in overweight and obese adults : a systematic review and meta-analysis of randomized controlled trials", Obes Surg, 30, pp.2743~2753 (2020)
50. Singh S, "Intragastric balloon versus endoscopic sleeve gastroplasty for the treatment of obesity : a systematic review and meta-analysis", Obes Surg, 30, pp.3010~3029 (2020)
51. Herve J, "What becomes of patients one year after the intragastric balloon has been removed?", Obes Surg, 15, pp.864~870 (2005)
52. Dastis NS, "Intragastric balloon for weight loss : results in 100 individuals followed for at least 2. 5 years", Endoscopy, 41, pp.575~580 (2009)
53. Tai CM, "Effectiveness of intragastric balloon treatment for obese patients : one-year follow-up after balloon removal", Obes Surg, 23, pp.2068~2074 (2013)
54. Dumonceau JM, "Evidence-based review of the Bioenterics intragastric balloon for weight loss", Obes Surg, 18, pp.1611~1617 (2008)
55. Ricci G, "Bariatric therapy with intragastric balloon improves liver dysfunction and insulin resistance in obese patients", Obes Surg, 18, pp.1438~1442 (2008)
56. Folini L, "Liver steatosis(LS)evaluated through chemical-shift magnetic resonance imaging liver enzymes in morbid obesity; effect of weight loss obtained with intragastric balloon gastric banding", Acta Diabetol, 51, pp.361~368 (2014)
57. Mafort TT, "Six-month intragastric balloon treatment for obesity improves lung function, body composition, and metabolic syndrome", Obes Surg, 24, pp.232~240 (2014)
58. Busetto L, "Obstructive sleep apnea syndrome in morbid obesity : effects of intragastric balloon", Chest, 128, pp.618~623 (2005)
59. Fuster JJ, "Obesity-induced changes in adipose tissue microenvironment and their impact on cardiovascular disease", Circ Res, 118, pp.1786~1807 (2016)
60. Martyniak K, "Changes in adipose tissue cellular composition during obesity and aging as a cause of metabolic dysregulation", Exp Gerontol, 94, pp.59~63 (2017)
61. Blüher M, "Adipose tissue inflammation: a cause or consequence of obesity-related insulin resistance?", Clin Sci (Lond), 130, pp.1603~1614 (2016)
62. Katsiki N, "Adiponectin, lipids and atherosclerosis", Curr Opin Lipidol, 28, pp.347~354 (2017)
63. Guedes MR, "Impact of intragastric balloon treatment on adipokines, cytokines, and metabolic profile in obese individuals", Obes Surg, 29, pp.2600~2608 (2019)
64. Popov VB, "The impact of intragastric balloons on obesity-related co-morbidities : a systematic review and meta-analysis", Am J Gastroenterol, 112, pp.429~439 (2017)
65. Popov VB, "Effect of intragastric balloons on liver enzymes : a systematic review and meta-analysis", Dig Dis Sci, 61, pp.2477~2487 (2016)
66. Mathus-Vliegen EM, "Gastro-oesophageal reflux in obese subjects : influence of overweight, weight loss and chronic gastric balloon distension", Scand J Gastroenterol, 37, pp.1246~1252 (2002)
67. Mathus-Vliegen EM, "Los function and obesity : the impact of untreated obesity, weight loss, and chronic gastric balloon distension", Digestion, 68, pp.161~168 (2003)
68. Rossi A, "Intragastric balloon insertion increases the frequency of erosive esophagitis in obese patients", Obes Surg, 17, pp.1346~1349 (2007)
69. Kim WY, "Large bowel impaction by the BioEnterics Intragastric Balloon(BIB)necessitating surgical intervention", Ann R Coll Surg Engl, 82, pp.202~204 (2000)
70. Vanden Eynden F, "Small intestine gastric balloon impaction treated by laparoscopic surgery", Obes Surg, 11, pp.646~648 (2001)
71. Lopez-Nava G, "Dual intragastric balloon : single ambulatory center Spanish experience with 60 patients in endoscopic weight loss management", Obes Surg, 25, pp.2263~2267 (2015)
72. Mathus-Vliegen EM, "Outcomes of intragastric balloon placements in a private practice setting", Endoscopy, 47, pp.302~307 (2015)

관련 논문AI추천